Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland

Michael Brändle, Katrina Erny-Albrecht, Giatgen Spinas, P. Streit, William Valentine

    Research output: Contribution to journalArticlepeer-review

    21 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)501-515
    Number of pages15
    JournalInternational Journal of Clinical Pharmacology and Therapeutics
    Issue number8
    Publication statusPublished - 2009

    Cite this